Lonza

Lonza, founded in 1897, is a prominent global supplier deeply integrated into the pharmaceutical, biotech, and specialty ingredients markets. With a significant operational footprint, the company provides a comprehensive portfolio of services and products. These include active pharmaceutical ingredients, drinking water sanitizers, nutritional and personal care ingredients, agricultural solutions, and industrial preservatives. Lonza's microbial control technologies are crucial for addressing harmful viruses, bacteria, and pathogens across various sectors. The company operates through two primary market-focused segments: Pharma & Biotech and Specialty Ingredients, underscoring its commitment to innovation and global health advancement. Learn about Lonza's global headquarters for detailed geographic information.

Operating with an employee base of Over 10,000 individuals, Lonza leverages its extensive expertise to serve a diverse clientele. Its offerings span from biopharmaceutical contract development and manufacturing to advanced cell and gene therapies, including AAV gene therapy. The Specialty Ingredients segment provides essential components for consumer goods, water treatment, and personal care. Lonza's strategic focus on innovation is evident in its development of cutting-edge solutions for life sciences and healthcare. Meet Lonza's team to understand the expertise driving its operations.

Lonza's market presence is substantial, evidenced by its reported revenue of $8.9B. The company competes with major players in the life sciences and chemical industries, including Catalent, Charles River, and Pfizer, among others. Its 59 locations worldwide facilitate its global reach and service delivery capabilities. Lonza's long history and continuous investment in research and development position it as a key partner for companies seeking advanced manufacturing and ingredient solutions.